Covid-19 disease and its impact on NET therapy (incl. somatostatin receptor targeted therapies)
Moderators: Marianne Ellen PAVEL
Introduction agenda and speakers
Panel: Wouter DE HERDER and John RAMAGE
General aspects of management of NEN patients in the COVID-19 era
COVID-19 and its impact on somatostatin receptor targeted therapies, including the use of SSA and the use of PRRT
These cookies are so-called "session cookies." They are automatically deleted after your visit.
Protects you from Cross-Site-Request-Forgery attacks.
Saves the current PHP session.
For webinar purposes, ENETS uses VIMEO as an embedded iframe on MY ENETS. VIMEO implements its own tracking system, which is beyond the of ENETS responsibility. By watching ENETS videos on the ENETS website, you also agree to the conditions of VIMEO: https://vimeo.com/privacy
This website uses Google Analytics, a web analytics service. It is operated by Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA. Google Analytics cookies are stored based on your consent Art. 6 (1) (a) DSGVO/GDPR, which we confirm via the consent banner.